Entyvio (vedolizumab)

Targeted Conditions

  • Ulcerative colitis (moderate to severe, in adults)
  • Crohn’s disease (moderate to severe, in adults)

Off-Label Usage

  • Limited studies in pediatric inflammatory bowel disease (IBD).
  • Investigational for other immune-mediated conditions, but not widely prescribed outside Crohn’s disease and ulcerative colitis.

Drug Classification Overview

Entyvio is a gut-selective biologic therapy (monoclonal antibody). It works by binding to the α4β7 integrin, which blocks the movement of inflammatory white blood cells into the gut. This reduces inflammation specifically in the gastrointestinal tract, unlike systemic immunosuppressants.

Manufacturer in the USA, Mexico, and Canada

  • 1
    United States: Takeda Pharmaceuticals America, Inc.
  • 2
    Canada: Takeda Canada Inc.
  • 3
    Mexico: Takeda México S.A. de C.V.

Available Strengths and Dosage Forms – United States, Mexico, and Canada

Country Comparison – United States vs Mexico and Canada

  • Approved in all three countries for the treatment of ulcerative colitis and Crohn’s disease.
  • Labeling, packaging, and prescribing guidelines may vary slightly across jurisdictions.

Average Retail Price (Monthly Treatment) USA vs Mexico vs Canada

  • 1
    Canada: Typically 20–30% savings compared to U.S. pricing.
  • 2
    Mexico: Typically 25–35% savings compared to U.S. pricing.

Savings are approximate, based on 2025 price data. They may vary depending on availability, prescription requirements, and cold-chain handling.

Where to Buy USA

  • Costco
  • CVS
  • Rite Aid
  • Walgreens
  • Walmart
  • Kroger
  • Albertsons
  • Sam’s Club
  • Publix
  • Target (via CVS Pharmacy)
  • Online mail-order specialty care pharmacies

Availability may vary depending on insurance coverage, specialty pharmacy networks, and prior authorization requirements.

Storage Requirements

  • Store in a refrigerator (2°C–8°C / 36°F–46°F).
  • Do not freeze.
  • Protect from light.
  • Keep vials in their original packaging until use.

Shipping from Canada

This medication is accessed through fully licensed Canadian pharmacies regulated by Health Canada. All pharmacies included in the MedicalMex network undergo a rigorous review and verification process to ensure compliance with national standards, patient safety, and medication authenticity.

MedicalMex facilitates:

  • Prescription verification and fulfillment coordination
  • Secure, compliant medication logistics
  • Access to licensed Canadian pharmacists
  • Access to our network of certified physicians if a Telehealth consultation is needed
  • Case management, payment handling, and personalized boutique-level support
  • Cold chain shipping with next-generation temperature-monitored coolers, when required
  • Refill tracking and patient adherence programs

You are working directly with MedicalMex Inc., a U.S.-based company that helps eligible patients safely access affordable medications from Canada — with compliance and full-service concierge support at every step.

Buying from Mexico

This medication is also available through certified pharmacies in Mexico regulated by COFEPRIS (Mexico’s national health authority). All partners in the MedicalMex network must pass a rigorous review and certification process before being approved for patient access.

MedicalMex facilitates:

  • Transportation support to our affiliate clinic in Tijuana, Mexico
  • Prescription handling through licensed physicians within our certified network
  • Access to our network of accredited physicians if a Telehealth consultation is needed
  • Travel coordination, including flights and/or hotel reservations when required
  • Travel insurance
  • Cold chain shipping with advanced temperature-monitored coolers, when applicable
  • Personalized, boutique-level service
  • Refill tracking and patient adherence support

You are working directly with MedicalMex Inc., a U.S.-based company that manages every detail — from medical and travel logistics to prescription compliance — providing secure, affordable access to life-saving medications from Mexico.

Key Benefits

  • Targets gut-specific inflammation without broad systemic immunosuppression.
  • Reduces symptoms of ulcerative colitis and Crohn’s disease.
  • Can help patients achieve and maintain remission.
  • Improves quality of life by reducing hospitalizations and flare-ups.

Side Effects

Common side effects:

  • Headache
  • Joint pain
  • Nausea
  • Fever
  • Fatigue
  • Upper respiratory tract infections

Serious but less common side effects:

  • Allergic reactions including rash, itching, or breathing difficulties
  • Liver injury (rare)
  • Increased risk of infections
  • Progressive multifocal leukoencephalopathy (PML) risk is extremely rare but monitored

Warnings and Precautions

  • Must be administered in a medical setting via IV infusion.
  • Monitor patients for signs of infection.
  • Avoid use in patients with active severe infections.
  • Hypersensitivity reactions may occur.
  • Limited safety data for pregnant or breastfeeding women; consult healthcare provider.

Alternative Medications (by Indication)

  • Remicade (infliximab): Biologic for IBD.
  • Humira (adalimumab): Biologic for ulcerative colitis and Crohn’s disease.
  • Stelara (ustekinumab): Biologic for Crohn’s disease and ulcerative colitis.
  • Xeljanz (tofacitinib): JAK inhibitor approved for ulcerative colitis.

Medication FAQs

Entyvio is prescribed for adults with moderate to severe ulcerative colitis or Crohn’s disease who have not responded well to other therapies.
It is given by intravenous (IV) infusion in a healthcare setting. After the initial dosing schedule, it is typically infused every 8 weeks.
Entyvio is gut-selective, meaning it mainly affects the digestive tract rather than the whole body, unlike systemic immunosuppressants.
Some patients notice improvements within a few weeks, but it may take several months for full benefit.
Yes. It is often prescribed alongside other treatments under specialist supervision.
Yes. Your doctor may order blood tests and monitor for infections and liver function.
Entyvio is currently approved only for adults, though pediatric studies are ongoing.
Yes, like other biologics, it may increase the risk of infections. Your doctor will screen for certain conditions before starting therapy.
No. It helps manage symptoms and maintain remission but does not cure these conditions.
Yes. Patient support programs may be available in the U.S., Canada, and Mexico. MedicalMex can assist patients in exploring affordable access options.